SARS-CoV-2 infection and glucose homeostasis in pregnancy. What about antenatal corticosteroids?
Fecha
2020Autor
Kakoulidis, Ioannis
Ilias, Ioannis
Koukkou, Eftychia
Documentos PDF
Imagenes y Videos
Resumen
Background and aims: Administration of corticosteroids is common in obstetric practice. In this concise
review we queried on the effects of corticosteroids in pregnancies complicated by SARS-CoV-2.
Methods: We performed a literature search on PubMed, regarding the use of corticosteroids in patients
with SARS-CoV-2 infection, in pregnancies complicated by SARS-CoV-2, as well as their impact on glycemia in pregnant women with or without diabetes. Furthermore, we searched for effects of SARS-CoV-2
and of other coronaviridae on insulin secretion and glycemia.
Results: SARS-CoV-2 infection appears to be a risk factor for complications in pregnancy. Corticosteroids
may not be recommended for treating SARS-CoV-2 pneumonia but they may be needed for at-risk
pregnancies. Corticosteroids in pregnancy have a diabetogenic potential. SARS-CoV-2 and other coronaviridae may have effects on glycemia.
Palabras clave
SARS-CoV-2; Coronavirus; Hyperglycemia; Betamethasone; InsulinEnlace al recurso
https://doi.org/10.1016/j.dsx.2020.04.045Colecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.